Skip to main content
Equibles
CELC logo

CELC · Celcuity Inc. · Webcasts, Transcripts & Audio

Track CELC — free

Use CELC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CELC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$69.78 -2.32 (-3.21%)
Russell 2000 member Rebalance outlook locked
Market Cap
$3.96B
Shares
48.93M
Volume · Oct 5 138.15K Avg daily vol (3M) 1.17M

Celcuity Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Celcuity Inc. (CELC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-08
Celcuity Inc. (CELC) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-13
Celcuity Inc. (CELC) Q2 2026 Earnings Call Transcript
Confident tone Victoria I Phase III data and SNDA submission FDA approval and commercial launch of RevTorPic Victoria II first-line breast cancer expansion
Diluted EPS
$-1.44
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-07-14
Celcuity Inc. (CELC) July 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-10
Celcuity Inc. (CELC) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
Celcuity Inc. (CELC) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-06-02
Celcuity Inc. (CELC) Q1 2026 Earnings Call Transcript
Confident tone Second-line HR+ HER2- advanced breast cancer setting Forward-looking statements / risk disclosures Gedatolisib drug profile
Diluted EPS
$-0.97
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Celcuity Inc. (CELC) Q4 2025 Earnings Call Transcript
Confident tone FDA NDA submission and PDUFA timeline International regulatory and partnership strategy Safety and tolerability profile of gedatolisib
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Celcuity Inc. (CELC) Q3 2025 Earnings Call Transcript
Confident tone NDA Submission and FDA Review VIKTORIA-1 Phase 3 Trial Results Balance Sheet and Financing
Diluted EPS
$-0.92
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2025-10-20
Celcuity Inc. (CELC) October 2025 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-14
Celcuity Inc. (CELC) Q2 2025 Earnings Call Transcript
Confident tone VIKTORIA-1 Phase III data Competitive landscape and positioning Commercial launch readiness
Diluted EPS
$-1.04
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Celcuity Inc. (CELC) Q1 2025 Earnings Call Transcript
Confident tone Gedatolisib commercial opportunity VIKTORIA-1 PIK3CA wild-type cohort Prostate cancer Phase 1b/2 program
Diluted EPS
$-0.86
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Celcuity Inc. (CELC) Q4 2024 Earnings Call Transcript
Confident tone VIKTORIA-1 Phase III trial and upcoming data readouts Tolerability and safety profile of gedatolisib VIKTORIA-2 Phase III first-line trial site selection
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Celcuity Inc. (CELC) Q3 2024 Earnings Call Transcript
Confident tone VIKTORIA-1 Phase III Trial Progress VIKTORIA-2 First-Line Phase III Trial Breast Cancer Biology and Triplet Regimen Strategy
Diluted EPS
$-0.70
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Celcuity Inc. (CELC) Q2 2024 Earnings Call Transcript
Positive tone VIKTORIA-2 Phase III frontline study launch VIKTORIA-2 safety run-in design VIKTORIA-1 PIK3CA wild-type cohort timeline shift
Diluted EPS
$-0.62
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript
Confident tone Patient Population Advantages VIKTORIA-1 Phase III Trial Progress Safety Profile
Diluted EPS
$-0.64
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Celcuity Inc. (CELC) Q4 2023 Earnings Call Transcript
Confident tone Gedatolisib differentiation vs other PAM inhibitors VIKTORIA-1 Phase 3 trial progress and timeline Phase 1b gedatolisib + palbociclib + fulvestrant data
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Celcuity Inc. (CELC) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.83
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Celcuity Inc. (CELC) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.66
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Celcuity Inc. (CELC) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.55
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-23
Celcuity Inc. (CELC) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Celcuity Inc. (CELC) Q3 2022 Earnings Call Transcript
Diluted EPS
$-0.75
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-11
Celcuity Inc. (CELC) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.67
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Celcuity Inc. (CELC) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-23
Celcuity Inc. (CELC) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Celcuity Inc. (CELC) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Celcuity Inc. (CELC) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Celcuity Inc. (CELC) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-16
Celcuity Inc. (CELC) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Celcuity Inc. (CELC) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Celcuity Inc. (CELC) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Celcuity Inc. (CELC) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-12
Celcuity Inc. (CELC) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–32 of 32 webcasts
Key facts CIK 1603454 CUSIP 15102K100 13F (30d) 5 filings 5 filers Visit website Investor relations